Microvast Announces Appointment of New Executive Officers
STAFFORD, Texas–(BUSINESS WIRE)–Microvast Holdings, Inc. (NASDAQ: MVST) (“Microvast” or the “Company”), a technology innovator that…
STAFFORD, Texas–(BUSINESS WIRE)–Microvast Holdings, Inc. (NASDAQ: MVST) (“Microvast” or the “Company”), a technology innovator that…
New Book “Own Your Past, Change Your Future” Available Now NASHVILLE, Tenn.–(BUSINESS WIRE)–It’s no secret…
CHICAGO–(BUSINESS WIRE)–Monroe Capital LLC has been recognized by Global M&A Network as the Small Mid-Markets…
Librestream’s Onsight solution, the leading augmented reality platform, set to support ReNew Power’s sustainability and…
Net Income for the 2022 First Quarter Increased $148.0 Million to a Record $338.5 Million,…
Immunicum AB (publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat…
ST. LOUIS, April 19, 2022 (GLOBE NEWSWIRE) — Curium announced today that it will be…
LONDON and RALEIGH, N.C., April 19, 2022 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…
The validated VAST and Vertica solution delivers real-time responsiveness for advanced analytics at a fraction…
TOKYO, Apr 19, 2022 – (JCN Newswire) – ENEOS Corporation and Mitsubishi Corporation have agreed…
Fazzaco Expo to make its debut in Dubai on October 12-13 at Festival City-Festival Arena…
TOKYO, Apr 19, 2022 – (JCN Newswire) – Mitsubishi Shipbuilding, a part of Mitsubishi Heavy…
ADELAIDE, AUS, Apr 19, 2022 – (ACN Newswire) – Avance Clinical, the largest premium Australian…
Singapore, Apr 19, 2022 – (ACN Newswire) – TechCreate Solutions Private Limited (“TechCreate”), a Singapore-based…
SAN DIEGO–(BUSINESS WIRE)–$IBM #classaction—The Class: Shareholder rights law firm Robbins LLP informs investors that a…
PHILADELPHIA, April 18, 2022 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company…
WESTMINSTER, Colo., April 18, 2022 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical…
IRVINE, Calif., April 18, 2022 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a…
DURHAM, N.C., April 18, 2022 (GLOBE NEWSWIRE) — Heat Biologics, Inc. (“Heat”) (NYSE American: HTBX),…
SAN DIEGO, April 18, 2022 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical…